PMID- 28943431 OWN - NLM STAT- MEDLINE DCOM- 20171020 LR - 20200310 IS - 1090-2104 (Electronic) IS - 0006-291X (Linking) VI - 493 IP - 2 DP - 2017 Nov 18 TI - Src-mediated ligand release-independent EGFR transactivation involves TGF-beta-induced Smad3 activation in mesangial cells. PG - 914-920 LID - S0006-291X(17)31892-2 [pii] LID - 10.1016/j.bbrc.2017.09.121 [doi] AB - A great deal of evidence highlighted the pathophysiologic importance of TGF-beta1/Smad3 pathway in masangial extracellular matrix (ECM) accumulation, but some alternative signaling pathways are also involved. TGF-beta was shown recently to induce rapid and transient epidermal-like growth factor receptor (EGFR) transactivation and subsequent fibronectin expression via heparin-binding epidermal-like growth factors (HB-EGF) release and binding in mesangial cells, which is independent of Smad2 activation. However, whether TGF-beta could induce persistent EGFR transactivation remains to be identified. The present study demonstrates that in addition to transient EGFR transactivation, TGF-beta1 can also induce continuous EGFR transactivation by a non-ligand-dependent pathway in rat mesangial cells. This sustained EGFR transactivation is mainly due to Src kinase-mediated persistent EGFR tyrosine phosphorylation at Y845 rather than Y1173. TGF-beta1-induced early Smad3 phosphorylation is independent of transient EGFR transactivation and ERK1/2 activation initiated by HB-EGF release, whereas Src-mediated chronic EGFR transactivation and ERK1/2 activation participate in Smad3 activation in a relatively modest and delayed manner. Therefore, the present study further clarifies the mechanisms of EGFR transactivation in the TGF-beta-initiated ECM upregulation and raises the possibility that targeting EGFR may provide a viable alternative strategy for inhibiting TGF-beta in chronic kidney disease. CI - Copyright (c) 2017. Published by Elsevier Inc. FAU - Chen, Yan AU - Chen Y AD - Department of Biochemistry and Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan University School of Basic Medical Sciences, Wuhan, PR China. FAU - Peng, Fang-Fang AU - Peng FF AD - Department of Biochemistry and Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan University School of Basic Medical Sciences, Wuhan, PR China. FAU - Jin, Jing AU - Jin J AD - Department of Biochemistry and Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan University School of Basic Medical Sciences, Wuhan, PR China. FAU - Chen, Hong-Min AU - Chen HM AD - Department of Biochemistry and Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan University School of Basic Medical Sciences, Wuhan, PR China. FAU - Yu, Hong AU - Yu H AD - Department of Biochemistry and Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan University School of Basic Medical Sciences, Wuhan, PR China. FAU - Zhang, Bai-Fang AU - Zhang BF AD - Department of Biochemistry and Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan University School of Basic Medical Sciences, Wuhan, PR China. Electronic address: zbfwq@whu.edu.cn. LA - eng PT - Journal Article DEP - 20170922 PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (Smad3 Protein) RN - 0 (Smad3 protein, rat) RN - 0 (Transforming Growth Factor beta) RN - EC 2.7.10.1 (ErbB Receptors) RN - EC 2.7.10.2 (CSK Tyrosine-Protein Kinase) RN - EC 2.7.10.2 (src-Family Kinases) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 1) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 3) SB - IM MH - Animals MH - CSK Tyrosine-Protein Kinase MH - Cells, Cultured MH - ErbB Receptors/*genetics/metabolism MH - Mesangial Cells/*metabolism MH - Mitogen-Activated Protein Kinase 1/metabolism MH - Mitogen-Activated Protein Kinase 3/metabolism MH - Phosphorylation MH - Rats, Sprague-Dawley MH - Smad3 Protein/*metabolism MH - *Transcriptional Activation MH - Transforming Growth Factor beta/*metabolism MH - src-Family Kinases/*metabolism OTO - NOTNLM OT - EGFR OT - Fibronectin OT - Src OT - TGF-beta EDAT- 2017/09/26 06:00 MHDA- 2017/10/21 06:00 CRDT- 2017/09/26 06:00 PHST- 2017/09/11 00:00 [received] PHST- 2017/09/21 00:00 [accepted] PHST- 2017/09/26 06:00 [pubmed] PHST- 2017/10/21 06:00 [medline] PHST- 2017/09/26 06:00 [entrez] AID - S0006-291X(17)31892-2 [pii] AID - 10.1016/j.bbrc.2017.09.121 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 2017 Nov 18;493(2):914-920. doi: 10.1016/j.bbrc.2017.09.121. Epub 2017 Sep 22.